DGCI to Review Applications For Full Market Approval of Covaxin And Covishield Vaccine Today
Bharat Biotech had on Thursday announced that its 'Covaxin' was now a universal vaccine approved for both adults and children.
New Delhi, January 14: The Drugs Controller General of India (DCGI) headed Subject Expert Committee will on Friday review applications of SII and Bharat Biotech for Covishield and Covaxin vaccines for full market approval to the vaccines, said reports. Bharat Biotech had on Thursday announced that its 'Covaxin' was now a universal vaccine approved for both adults and children.
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)